# Microbiome Use to Stratify Use of Inhaled Corticosteroids: MUSIC Trial

> **NCT02972476** · PHASE4 · COMPLETED · sponsor: **University of Dundee** · enrollment: 158 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Budesonide & formoterol fumarate and Aclidinium bromide
- **DRUG:** Fluticasone 500 & salmeterol and Aclidinium bromide
- **DRUG:** Fluticasone 250 & salmeterol and Aclidinium bromide
- **DRUG:** Aclidinium bromide & formoterol fumarate

## Key facts

- **NCT ID:** NCT02972476
- **Lead sponsor:** University of Dundee
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2019-07-22
- **Final completion:** 2019-07-22
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2020-07-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02972476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02972476, "Microbiome Use to Stratify Use of Inhaled Corticosteroids: MUSIC Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02972476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*